Delafloxacin Meglumine Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 450 mg

Reference Brands: Baxdela (USA/EU)

Category: Antibiotics

Product Description:

Delafloxacin, sold under the brand name Baxdela, is a broad-spectrum fluoroquinolone antibiotic used for the treatment of acute bacterial infections. It is primarily indicated for adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Additionally, delafloxacin is approved for the treatment of community-acquired bacterial pneumonia (CABP) in adults caused by designated susceptible pathogens.

Delafloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair, thereby preventing bacterial growth and proliferation. It is available in both intravenous and oral formulations, allowing flexible treatment options and seamless transition from hospital to outpatient care. The medication is formulated as delafloxacin meglumine for IV administration and as delafloxacin tablets for oral use, ensuring optimal bioavailability and efficacy.

Developed and commercialized under the brand name Baxdela, delafloxacin is manufactured in compliance with international regulatory standards, including US FDA and EU GMP guidelines. It offers healthcare providers a potent and versatile option for managing complicated bacterial infections in adult patients.